Skip to content

Enterprise value at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
Danaher logo
DanaherDHR
$148.16B-8.7%
Agilent Technologies logo
Agilent TechnologiesA
$34.39B+5.1%
Illumina logo
IlluminaILMN
$19.8B+46.0%
TEC
Bio-TechneTECH
$8.26B-13.6%
Revvity logo
RevvityRVTY
$12.88B-13.7%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Calculated from Twist Bioscience Corporation’s reported figures.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's enterprise value?
Twist Bioscience Corporation (TWST) reported enterprise value of $2.9B in Q1 2026.
How has Twist Bioscience Corporation's enterprise value changed year-over-year?
Twist Bioscience Corporation's enterprise value increased by 30.4% year-over-year, from $2.22B to $2.9B.
What is the long-term trend for Twist Bioscience Corporation's enterprise value?
Over 5 years (2020 to 2025), Twist Bioscience Corporation's enterprise value has grown at a -15.5% compound annual growth rate (CAGR), from $3.71B to $1.6B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.